110 related articles for article (PubMed ID: 6155208)
1. Pilot study of vinblastine and bleomycin combinations in the treatment of metastatic melanoma.
Nathanson L; Wittenberg BK
Cancer Treat Rep; 1980 Jan; 64(1):133-7. PubMed ID: 6155208
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.
Johnson DH; Presant C; Einhorn L; Bartolucci AA; Greco FA
Cancer Treat Rep; 1985; 69(7-8):821-4. PubMed ID: 2410120
[TBL] [Abstract][Full Text] [Related]
3. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
[TBL] [Abstract][Full Text] [Related]
4. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
Bajetta E; Rovej R; Buzzoni R; Vaglini M; Bonadonna G
Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Kelsen DP; Bains M; Chapman R; Golbey R
Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
[TBL] [Abstract][Full Text] [Related]
6. Variables for predicting serious toxicity (vinblastine dose, performance status, and prior therapeutic experience): chemotherapy for metastatic testicular cancer with cis-dichlorodiammineplatinum(II), vinblastine, and bleomycin.
Krikorian JG; Daniels JR; Brown BW; Hu MS
Cancer Treat Rep; 1978 Oct; 62(10):1455-63. PubMed ID: 81719
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study.
Samson MK; Stephens RL; Rivkin S; Opipari M; Maloney T; Groppe CW; Fisher R
Cancer Treat Rep; 1979; 63(9-10):1663-7. PubMed ID: 91435
[TBL] [Abstract][Full Text] [Related]
8. Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma.
Nathanson L; Kaufman SD; Carey RW
Cancer; 1981 Sep; 48(6):1290-4. PubMed ID: 6168365
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of the combination of vinblastine, bleomycin, and cisplatin in advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Mar; 66(3):567-9. PubMed ID: 6174231
[No Abstract] [Full Text] [Related]
10. Sequential combination chemotherapy with vinblastine-bleomycin and doxorubicin-cis-dichlorodiammineplatinum(II) in disseminated nonseminomatous testicular cancer.
Scheulen ME; Seeber S; Schilcher RB; Meier CR; Schmidt CG
Cancer Treat Rep; 1980; 64(4-5):599-609. PubMed ID: 6159077
[TBL] [Abstract][Full Text] [Related]
11. Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma.
Richman SP; Woodcock TM; Kubota TT; Blumenreich MS; Gentile PS; Allegra JC
Cancer Treat Rep; 1984 Nov; 68(11):1395-6. PubMed ID: 6209008
[No Abstract] [Full Text] [Related]
12. Combination of vinblastine and bleomycin in metastatic renal cell carcinoma.
Knost JA; Oldham RK; Hande KR; Rhamy RK; Greco FA
Cancer Treat Rep; 1981; 65(3-4):349-50. PubMed ID: 6165469
[No Abstract] [Full Text] [Related]
13. cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.
Kelsen DP; Cvitkovic E; Bains M; Shils M; Howard J; Hopfan S; Golbey RB
Cancer Treat Rep; 1978 Jul; 62(7):1041-6. PubMed ID: 80269
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
[TBL] [Abstract][Full Text] [Related]
15. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for advanced cervical cancer with methotrexate, bleomycin, and cis-dichlorodiammineplatinum(II).
Vogl SE; Moukhtar M; Kaplan BH
Cancer Treat Rep; 1979 Jun; 63(6):1005-6. PubMed ID: 89007
[TBL] [Abstract][Full Text] [Related]
17. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
18. Vinblastine, bleomycin, and cis-platinum for the treatment of metastatic malignant melanoma. National Cancer Institute of Canada Melanoma Group.
J Clin Oncol; 1984 Feb; 2(2):131-4. PubMed ID: 6199480
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Green SJ
Cancer Treat Rep; 1982 Jun; 66(6):1425-6. PubMed ID: 7083244
[TBL] [Abstract][Full Text] [Related]
20. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
